Articles From: St. Jude Medical to Present Data from 16 Research Abstracts and Highlight Its Product Portfolio at the 2014 North American Neuromodulation Society Meeting to VIVINT SOLAR SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Vivint Solar, Inc. -- VSLR


St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, will present data from 16 clinical research programs at the upcoming North American Neuromodulation Society (NANS) meeting in Las Vegas, Nevada, December 11 – 14, 2014.
Sign-up for St. Jude Medical to Present Data from 16 Research Abstracts and Highlight Its Product Portfolio at the 2014 North American Neuromodulation Society Meeting investment picks
LAFAYETTE, La., Dec.
Sign-up for Stone Energy Corporation Announces Successful Utica Shale Exploration Well investment picks
Strategic Global Income Fund, Inc. (the "Fund") (NYSE:SGL), a non-diversified, closed-end management investment company seeking a high level of current income as a primary objective and capital appreciation as a secondary objective through investments in US and foreign debt securities, today announced that the Fund’s Board of Directors declared a regular monthly distribution of $0.0422 per share.
Sign-up for Strategic Global Income Fund, Inc. – Distribution Declaration and Updated Price & Distribution Rate Information investment picks
Sundance Strategies, Inc. (OTCBB: SUND), an innovative company engaged in acquiring life insurance settlements and related insurance contracts, policies and obligations, today announced that it has signed a binding Letter of Intent (“LOI”) to acquire a portfolio of life insurance policies from a life settlement fund.
Sign-up for Sundance Strategies Signs Binding Letter of Intent to Acquire Portfolio of Life Insurance Policies with Face Value of Approximately $124 Million investment picks
TD Ameritrade, Inc. (“TD Ameritrade”), a broker-dealer subsidiary of TD Ameritrade Holding Corporation (NYSE:AMTD), is today releasing the Investor Movement Index ® reading for November 2014.
Sign-up for TD Ameritrade’s Investor Movement Index: IMX Double Dips in November investment picks
http://media.marketwire.com/attachments/201301/120346_ThompsonCreek-Logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163664&ProfileId=051205&sourceType=1 DENVER, CO --
Sign-up for Thompson Creek Metals Company Announces Change in Senior Management investment picks
Foundation Medicine, Inc. (NASDAQ:FMI) today announced new data demonstrating that its comprehensive genomic profile, FoundationOne® Heme , identified genomic alterations in patients with heavily pre-treated multiple myeloma that informed treatment with trametinib, an FDA-approved targeted therapeutic agent 1 .
Sign-up for Treatment for Relapsed Multiple Myeloma Patients Guided by FoundationOne® Heme Results in Promising Clinical Activity investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0982918001&sourceType=1 http://www.ccnmatthews.com/logos/20100302-trilogy.jpg CALGARY, ALBERTA --
Sign-up for Trilogy Energy Corp. Announces Intention to Implement a Normal Course Issuer Bid, Announces Discontinuance of Dividend and Provides 2015 Guidance investment picks
2014/12/8
WILMINGTON, Mass., Dec.
Sign-up for UniFirst CEO Named Executive of the Year by Best in Biz Awards 2014 investment picks
2014/12/8
Continued growth of distributed energy resources and energy efficiency measures could cause significant demand disruption and drive down utilities’ revenues by up to $48 billion a year in the United States and €61 billion a year in Europe by 2025, according to Accenture’s Digitally Enabled Grid research.
Sign-up for Utilities Face Significant Revenue Losses from Growth of Solar, Storage and Energy Efficiency, Accenture Research Shows investment picks
Vanguard Natural Resources, LLC (NASDAQ: VNR) (“Vanguard”) today announced that Scott W.
Sign-up for Vanguard Natural Resources, LLC to Present at the Wells Fargo Energy Symposium investment picks
- Line of 17 models of the VSI Radial™ introducer sheath targets vascular access needs in the rapidly-growing radial artery catheterization market - Developed and manufactured by LePu Medical of Beijing, China, building on the successful initial collaboration for the Vasc™ Band radial hemostat - Vascular Solutions expects to launch the VSI Radial introducer sheath in January MINNEAPOLIS, Dec.
Sign-up for Vascular Solutions Announces FDA 510(k) Clearance of VSI Radial Introducer Sheath investment picks
2014/12/8
NEW YORK , Dec.
Sign-up for Verizon Names New General Counsel and Public Policy Lead investment picks
FORT WASHINGTON, Pa., Dec.
Sign-up for Vitae Pharmaceuticals Among 2014 Best Places to Work in PA investment picks
2014/12/8
BETHESDA, Md.
Sign-up for Walker & Dunlop is Recognized as a Great Rated!™ Employer investment picks
WGL Holdings, Inc. (NYSE: WGL), through its subsidiary, Washington Gas Energy Systems ( WGESystems ), announced an agreement with Southern Company and the Electric Power Research Institute (EPRI) to test and evaluate a battery storage system at a 1-megawatt (MW) solar array in Cedartown, Ga.
Sign-up for Washington Gas Energy Systems to Evaluate Battery Storage System for Solar Energy in Cedartown, Georgia investment picks
By Tomi Kilgore, MarketWatch Toll Brothers has beat profit, sales expectations for the past four quarters Investors appear to have high hopes for Toll Brothers Inc., which reports fiscal fourth-quarter results before the market opens on Wednesday.
Sign-up for What to expect from Toll Brothers' earnings investment picks
http://media.marketwire.com/attachments/201401/219843_WVO_3C_RGB.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163580&ProfileId=051205&sourceType=1 ORLANDO, FL --
Sign-up for Wyndham Vacation Ownership Named Among "Best Places to Work" in Southern Nevada investment picks
Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the presentation of preliminary data from the luspatercept phase 2 clinical trial in patients with beta-thalassemia at the 56 th American Society of Hematology (ASH) Annual Meeting and Exposition.
Sign-up for New Data from Luspatercept Phase 2 Clinical Trial in Beta-Thalassemia Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition investment picks
-Only Rentrak Provides the Official Global Movie Results- LOS ANGELES , Dec.
Sign-up for Rentrak Announces Official Worldwide Box Office Results for Weekend of December 7, 2014 investment picks
Iron Ore 58% Fe, Low Alumina, CFR China (TSI) Futures to Launch December 8 NEW YORK and SINGAPORE, Dec.
Sign-up for TSI Iron Ore Fines Index to Form Basis of New CME Futures Contract investment picks
http://media.marketwire.com/attachments/201412/294981_2395-2013_Zebra_Tag_Horizontal.jpg.jpeg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163308&ProfileId=051205&sourceType=1 SINGAPORE --
Sign-up for Zebra Technologies Strengthens Leadership Across APAC investment picks
Bristol-Myers Squibb Company (NYSE:BMY) today announced positive results from a cohort of patients in its ongoing Phase 1b trial (CheckMate -039) which evaluated PD-1 immune checkpoint inhibitor, Opdivo (nivolumab), in patients with relapsed or refractory hematological malignancies (n=23). Results showed high levels of response in patients with relapsed or refractory classical Hodgkin Lymphoma (HL), with an overall response rate of 87% (n=20) and stable disease in 13% (n=3). These findings were published today in The New England Journal of Medicine ( NEJM ) and highlighted in the press briefing on Saturday, December 6 during the 56 th annual meeting of the American Society for Hematology (Abstract #289). In patients with HL, initial treatment typically consists of chemotherapy and/or radiation therapy, followed by an autologous stem cell
Sign-up for Opdivo (nivolumab) Demonstrates High Overall Response Rate of 87% for Treatment of Relapsed or Refractory Hodgkin Lymphoma investment picks
2014/12/6
By Quentin Fottrell, MarketWatch The Material Girl wasn't kidding around.
Sign-up for UPDATE: 10 richest musicians in the world investment picks
2014/12/6
By Charles Passy, MarketWatch 1.
Sign-up for UPDATE: 10 things Chipotle won't tell you investment picks
2014/12/6
By Catey Hill, MarketWatch Last year, more than 11 million toys were recalled, according to the public interest nonprofit group U.S. PIRG Education Fund -- many because they posed a danger to children.
Sign-up for UPDATE: 8 popular, but potentially dangerous, toys for kids investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: St. Jude Medical to Present Data from 16 Research Abstracts and Highlight Its Product Portfolio at the 2014 North American Neuromodulation Society Meeting to VIVINT SOLAR SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Vivint Solar, Inc. -- VSLR
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent